• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Overview of the genetics of major depressive disorder.重度抑郁症的遗传学概述。
Curr Psychiatry Rep. 2010 Dec;12(6):539-46. doi: 10.1007/s11920-010-0150-6.
2
Genetic polymorphisms in the serotonergic system and symptom clusters of major depressive disorder.5-羟色胺能系统的遗传多态性与重性抑郁障碍的症状群。
J Affect Disord. 2011 Dec;135(1-3):374-6. doi: 10.1016/j.jad.2011.08.027. Epub 2011 Sep 13.
3
Genetics of unipolar major depressive disorder.单相重度抑郁症的遗传学
Isr J Psychiatry Relat Sci. 2010;47(1):72-82.
4
Association between serotonin 2A receptor (HTR2A), serotonin transporter (SLC6A4) and brain-derived neurotrophic factor (BDNF) gene polymorphisms and citalopram/sertraline induced sexual dysfunction in MDD patients.5-羟色胺 2A 受体(HTR2A)、5-羟色胺转运体(SLC6A4)和脑源性神经营养因子(BDNF)基因多态性与西酞普兰/舍曲林治疗 MDD 患者所致性功能障碍的相关性。
Pharmacogenomics J. 2020 Jun;20(3):443-450. doi: 10.1038/s41397-019-0127-8. Epub 2019 Dec 3.
5
Genetic variation in the tryptophan hydroxylase 2 gene moderates depressive symptom trajectories and remission over 8 weeks of escitalopram treatment.色氨酸羟化酶2基因的遗传变异可调节艾司西酞普兰治疗8周期间的抑郁症状轨迹及缓解情况。
Int Clin Psychopharmacol. 2016 May;31(3):127-33. doi: 10.1097/YIC.0000000000000115.
6
Association of serotonin transporter (SLC6A4) and receptor (5HTR1A, 5HTR2A) polymorphisms with response to treatment with escitalopram in patients with major depressive disorder: A preliminary study.血清素转运体(SLC6A4)及受体(5HTR1A、5HTR2A)基因多态性与重度抑郁症患者对艾司西酞普兰治疗反应的相关性:一项初步研究。
Indian J Med Res. 2015 Jul;142(1):40-5. doi: 10.4103/0971-5916.162094.
7
Gene-environment interactions in major depressive disorder.重性抑郁障碍的基因-环境相互作用。
Can J Psychiatry. 2013 Feb;58(2):76-83. doi: 10.1177/070674371305800203.
8
Genetics of emergent suicidality during antidepressive treatment--data from a naturalistic study on a large sample of inpatients with a major depressive episode.抗抑郁治疗中出现自杀倾向的遗传学研究——一项对大量重性抑郁发作住院患者进行的自然研究数据
Eur Neuropsychopharmacol. 2013 Jul;23(7):663-74. doi: 10.1016/j.euroneuro.2012.08.009. Epub 2012 Oct 11.
9
Genetic polymorphism involved in major depressive disorder: a systemic review and meta-analysis.遗传多态性与重度抑郁症的关联:系统评价和荟萃分析。
BMC Psychiatry. 2024 Oct 22;24(1):716. doi: 10.1186/s12888-024-06195-z.
10
Suicide behavior as a quantitative trait and its genetic background.自杀行为作为一种数量性状及其遗传背景。
J Affect Disord. 2016 Dec;206:241-250. doi: 10.1016/j.jad.2016.07.029. Epub 2016 Jul 19.

引用本文的文献

1
Could thyrotropin serum level characterize major depressive disorder phenotype? A systematic review and meta-analysis.促甲状腺激素血清水平能否表征重度抑郁症的表型?一项系统评价与荟萃分析。
J Endocrinol Invest. 2025 Aug 19. doi: 10.1007/s40618-025-02687-1.
2
Neuroimaging correlates of psychological resilience: an Open Science systematic review and meta-analysis.心理韧性的神经影像学关联:一项开放科学系统综述与荟萃分析
Front Neuroimaging. 2025 May 13;4:1487888. doi: 10.3389/fnimg.2025.1487888. eCollection 2025.
3
Secondary analysis of GenRED data (Genetics of Recurrent Early-Onset major Depression) using MERLIN.使用MERLIN对GenRED数据(复发性早发性重度抑郁症的遗传学数据)进行二次分析。
Eur Arch Psychiatry Clin Neurosci. 2025 Apr 26. doi: 10.1007/s00406-025-02014-y.
4
Epigenomics and the Brain-gut Axis: Impact of Adverse Childhood Experiences and Therapeutic Challenges.表观基因组学与脑-肠轴:童年不良经历的影响及治疗挑战
J Transl Gastroenterol. 2024 Jun;2(2):125-130. doi: 10.14218/JTG.2024.00017. Epub 2024 Jun 28.
5
Circular RNAs in neurological conditions - computational identification, functional validation, and potential clinical applications.神经疾病中的环状RNA——计算识别、功能验证及潜在临床应用
Mol Psychiatry. 2025 Apr;30(4):1652-1675. doi: 10.1038/s41380-025-02925-1. Epub 2025 Feb 17.
6
Evaluating Apelin as a Potential Biomarker in Major Depressive Disorder: Its Correlation with Clinical Symptomatology.评估Apelin作为重度抑郁症潜在生物标志物:其与临床症状学的相关性。
Int J Mol Sci. 2024 Dec 20;25(24):13663. doi: 10.3390/ijms252413663.
7
Exploring miRNA Biomarkers in Major Depressive Disorder: A Molecular Medicine Perspective.从分子医学角度探索重度抑郁症中的微小RNA生物标志物
Curr Issues Mol Biol. 2024 Sep 27;46(10):10846-10853. doi: 10.3390/cimb46100644.
8
Genetic polymorphism involved in major depressive disorder: a systemic review and meta-analysis.遗传多态性与重度抑郁症的关联:系统评价和荟萃分析。
BMC Psychiatry. 2024 Oct 22;24(1):716. doi: 10.1186/s12888-024-06195-z.
9
Deciphering the role of miRNA-134 in the pathophysiology of depression: A comprehensive review.解读miRNA - 134在抑郁症病理生理学中的作用:一项综合综述。
Heliyon. 2024 Oct 5;10(19):e39026. doi: 10.1016/j.heliyon.2024.e39026. eCollection 2024 Oct 15.
10
Association of HHV‑6 reactivation and SLC6A3 (C>T, rs40184), BDNF (C>T, rs6265), and JARID2 (G>A, rs9383046) single nucleotide polymorphisms in depression.抑郁症中HHV-6再激活与SLC6A3(C>T,rs40184)、BDNF(C>T,rs6265)及JARID2(G>A,rs9383046)单核苷酸多态性的关联
Biomed Rep. 2024 Oct 3;21(6):181. doi: 10.3892/br.2024.1869. eCollection 2024 Dec.

本文引用的文献

1
Brain-derived neurotrophic factor as a biomarker for mood disorders: an historical overview and future directions.脑源性神经营养因子作为心境障碍的生物标志物:历史概述与未来方向。
Psychiatry Clin Neurosci. 2010 Aug;64(4):341-57. doi: 10.1111/j.1440-1819.2010.02113.x.
2
Genome-wide association study of major recurrent depression in the U.K. population.全基因组关联研究在英国人群中的主要复发性抑郁。
Am J Psychiatry. 2010 Aug;167(8):949-57. doi: 10.1176/appi.ajp.2010.09091380. Epub 2010 Jun 1.
3
Genetic sensitivity to the environment: the case of the serotonin transporter gene and its implications for studying complex diseases and traits.遗传对环境的敏感性:以血清素转运体基因为例,及其对研究复杂疾病和特征的意义。
Am J Psychiatry. 2010 May;167(5):509-27. doi: 10.1176/appi.ajp.2010.09101452. Epub 2010 Mar 15.
4
The serotonin transporter polymorphism (5-HTTLPR): allelic variation and links with depressive symptoms.5-羟色胺转运体基因多态性(5-HTTLPR):等位基因变异与抑郁症状的关联。
Depress Anxiety. 2010 Mar;27(3):260-9. doi: 10.1002/da.20660.
5
The role of BDNF and its receptors in depression and antidepressant drug action: Reactivation of developmental plasticity.脑源性神经营养因子及其受体在抑郁症和抗抑郁药物作用中的作用:发育可塑性的再激活。
Dev Neurobiol. 2010 Apr;70(5):289-97. doi: 10.1002/dneu.20758.
6
Genome-wide association study of recurrent early-onset major depressive disorder.全基因组关联研究复发性早发性重度抑郁症。
Mol Psychiatry. 2011 Feb;16(2):193-201. doi: 10.1038/mp.2009.124. Epub 2010 Feb 2.
7
Pharmacogenetic considerations in the treatment of psychiatric disorders.精神障碍治疗中的药物遗传学考虑因素。
Expert Opin Pharmacother. 2010 Feb;11(3):423-39. doi: 10.1517/14656560903508762.
8
Meta-analysis of genome-wide association data identifies a risk locus for major mood disorders on 3p21.1.全基因组关联数据分析确定了 3p21.1 上主要心境障碍的风险位点。
Nat Genet. 2010 Feb;42(2):128-31. doi: 10.1038/ng.523. Epub 2010 Jan 17.
9
Novel loci for major depression identified by genome-wide association study of Sequenced Treatment Alternatives to Relieve Depression and meta-analysis of three studies.通过对缓解抑郁症的序贯治疗选择的全基因组关联研究以及三项研究的荟萃分析,确定了重度抑郁症的新基因座。
Mol Psychiatry. 2011 Feb;16(2):202-15. doi: 10.1038/mp.2009.125. Epub 2009 Dec 29.
10
The moderation by the serotonin transporter gene of environmental adversity in the etiology of depression: 2009 update.抑郁发生的病因学中,5-羟色胺转运体基因对环境逆境的调节作用:2009 更新。
Mol Psychiatry. 2010 Jan;15(1):18-22. doi: 10.1038/mp.2009.123.

重度抑郁症的遗传学概述。

Overview of the genetics of major depressive disorder.

机构信息

Department of Psychiatry, University of Pennsylvania School of Medicine, Center for Neurobiology and Behavior, Philadelphia, 19104, USA.

出版信息

Curr Psychiatry Rep. 2010 Dec;12(6):539-46. doi: 10.1007/s11920-010-0150-6.

DOI:10.1007/s11920-010-0150-6
PMID:20848240
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3077049/
Abstract

Major depressive disorder (MDD) is a common psychiatric illness with high levels of morbidity and mortality. Despite intensive research during the past several decades, the neurobiological basis and pathophysiology of depressive disorders remain unknown. Genetic factors play important roles in the development of MDD, as indicated by family, twin, and adoption studies, and may reveal important information about disease mechanisms. This article describes recent developments in the field of psychiatric genetics, with a focus on MDD. Early twin studies, linkage studies, and association studies are discussed. Recent findings from genome-wide association studies are reviewed and future directions discussed. Despite all efforts, thus far, no single genetic variation has been identified to increase the risk of depression substantially. Genetic variants are expected to have only small effects on overall disease risk, and multiple genetic factors in conjunction with environmental factors are likely necessary for the development of MDD. Future large-scale studies are needed to dissect this complex phenotype and to identify pathways involved in the etiology of MDD.

摘要

重性抑郁障碍(MDD)是一种常见的精神疾病,发病率和死亡率都很高。尽管在过去几十年中进行了深入研究,但抑郁障碍的神经生物学基础和病理生理学仍不清楚。遗传因素在 MDD 的发展中起着重要作用,这一点可以从家族、双胞胎和收养研究中得到证实,并且可能揭示有关疾病机制的重要信息。本文描述了精神遗传学领域的最新进展,重点是 MDD。讨论了早期的双胞胎研究、连锁研究和关联研究。回顾了全基因组关联研究的最新发现,并讨论了未来的方向。尽管迄今为止已经付出了所有努力,但尚未发现任何单一的遗传变异可以显著增加患抑郁症的风险。遗传变异预计对整体疾病风险的影响很小,并且 MDD 的发生可能需要多个遗传因素与环境因素共同作用。未来需要进行大规模研究来剖析这种复杂的表型,并确定与 MDD 病因相关的途径。